CCCC
Price
$1.59
Change
-$0.15 (-8.57%)
Updated
Mar 31, 04:59 PM (EDT)
Capitalization
124.23M
38 days until earnings call
HUMA
Price
$1.71
Change
-$0.25 (-12.76%)
Updated
Mar 31, 04:59 PM (EDT)
Capitalization
301.19M
39 days until earnings call
Ad is loading...

CCCC vs HUMA

Header iconCCCC vs HUMA Comparison
Open Charts CCCC vs HUMABanner chart's image
C4 Therapeutics
Price$1.59
Change-$0.15 (-8.57%)
Volume$7.97K
Capitalization124.23M
Humacyte
Price$1.71
Change-$0.25 (-12.76%)
Volume$95.62K
Capitalization301.19M
CCCC vs HUMA Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. HUMA commentary
Mar 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and HUMA is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 31, 2025
Stock price -- (CCCC: $1.75 vs. HUMA: $1.96)
Brand notoriety: CCCC and HUMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 35% vs. HUMA: 423%
Market capitalization -- CCCC: $124.23M vs. HUMA: $301.19M
CCCC [@Biotechnology] is valued at $124.23M. HUMA’s [@Biotechnology] market capitalization is $301.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileHUMA’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • HUMA’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than HUMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 5 TA indicator(s) are bullish while HUMA’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 5 bullish, 3 bearish.
  • HUMA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than HUMA.

Price Growth

CCCC (@Biotechnology) experienced а -17.45% price change this week, while HUMA (@Biotechnology) price change was -40.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.00%. For the same industry, the average monthly price growth was -10.65%, and the average quarterly price growth was -10.07%.

Reported Earning Dates

CCCC is expected to report earnings on May 08, 2025.

HUMA is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (-9.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HUMA($301M) has a higher market cap than CCCC($124M). CCCC YTD gains are higher at: -51.389 vs. HUMA (-61.188). CCCC has higher annual earnings (EBITDA): -103.37M vs. HUMA (-137.16M). CCCC has more cash in the bank: 245M vs. HUMA (20.6M). HUMA has less debt than CCCC: HUMA (17.3M) vs CCCC (65.8M). CCCC has higher revenues than HUMA: CCCC (35.6M) vs HUMA (0).
CCCCHUMACCCC / HUMA
Capitalization124M301M41%
EBITDA-103.37M-137.16M75%
Gain YTD-51.389-61.18884%
P/E RatioN/AN/A-
Revenue35.6M0-
Total Cash245M20.6M1,189%
Total Debt65.8M17.3M380%
TECHNICAL ANALYSIS
Technical Analysis
CCCCHUMA
RSI
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Ad is loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CREYX9.97N/A
N/A
Columbia Real Estate Equity Inst3
PICEX6.51-0.09
-1.36%
Virtus SGA Emerging Markets Equity C
FEOPX15.54-0.28
-1.77%
Fidelity Enduring Opportunities
CEYIX91.72-1.67
-1.79%
Calvert Equity I
CLSPX24.75-0.58
-2.29%
Columbia Select Mid Cap Gro Fd I

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-4.89%
KYMR - CCCC
60%
Loosely correlated
-1.92%
FATE - CCCC
50%
Loosely correlated
-3.66%
PRME - CCCC
48%
Loosely correlated
+2.05%
CRBU - CCCC
48%
Loosely correlated
-5.02%
CRSP - CCCC
47%
Loosely correlated
-2.76%
More

HUMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HUMA has been loosely correlated with AURA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HUMA jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HUMA
1D Price
Change %
HUMA100%
-2.49%
AURA - HUMA
41%
Loosely correlated
+6.73%
RXRX - HUMA
40%
Loosely correlated
-2.68%
KYMR - HUMA
38%
Loosely correlated
-1.92%
CCCC - HUMA
35%
Loosely correlated
-4.89%
XERS - HUMA
35%
Loosely correlated
-0.89%
More